The largest database of trusted experimental protocols

Osteomark

Manufactured by Creative Diagnostics
Sourced in United States

Osteomark is a laboratory equipment product developed by Creative Diagnostics. It is designed for the analysis and measurement of bone metabolism markers.

Automatically generated - may contain errors

2 protocols using osteomark

1

Bone Mineral Density and Biochemical Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMD at the L2 to L4 lumbar spine (L-BMD) and total hip (H-BMD) were measured using dual-energy X-ray absorptiometry (GE Healthcare, WI, USA), and a quality assurance test was carried out on every measurement to detect machine drift. The interassay variance of the L-BMD measurement in our laboratory was 0.5 ± 0.5% (CV ± SD). Serum 25-hydroxyvitamin D (25 [OH] D) levels were measured using ECLIA. The serum level of calcium was corrected (cCa) based on the serum albumin level using the following formula: cCa = (Calcium + 4)-albumin. Serum levels of bone-derived alkaline phosphatase (BAP; Ostase CLEA; Beckman Coulter, Atlanta, GA, USA) and urinary excretion of type I collagen-cross-linked N-telopeptides (NTx; Osteomark; Creative Diagnostics, NY, USA) were also measured. The urinary excretion of pentosidine and plasma levels of total homocysteine were measured using an HPLC system after hydrolysis of the urine samples3 (link),4 (link). Plasma levels of total homocysteine were measured using an HPLC system. All chemical parameters mentioned above were measured at the central laboratory (LSI Medience, Tokyo, Japan).
+ Open protocol
+ Expand
2

Serum NOx, Bone Density, and Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum level of NOx (NO2 and NO3) was measured by colorimetric assay kit (Cayman Chemical, MI, USA) using Griess reagent. The inter- and intra-assay variances in the laboratory were 2.7% and 2.1%, respectively. In addition, we had checked intra-assay variance of serum samples obtained from 2 different time points in 10 participants. The coefficient of variation (CV) was 14.2 ± 9.2% (mean ± standard deviation). BMD at L2 to L4 lumbar spine (L-BMD) was determined by dual energy X-ray absorptiometry (DPX series, GE Healthcare, IL, USA). Serum levels of parathyroid hormone (PTH) and 25-hydroxyvitamin D (25[OH]D) were measured by electrochemiluminescence immunoassay (ECLIA). As for BTMs, serum level of bone-derived alkaline phosphatase (BAP; Ostase CLIA, Beckman Coulter, CA, USA) and urinary excretion of type I collagen cross-linked N-telopeptides (NTx; Osteomark, Creative Diagnostics, NY, USA) were measured. Serum homocysteine level was determined by using high-performance liquid chromatography (HPLC). Urinary excretion of pentosidine was measured by HPLC system after hydrolysis of urine samples [16 (link), 17 (link)]. All the biochemical parameters listed above were assayed at the central laboratory (LSI Medience, Tokyo, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!